Antibody-based inhibitors specifically targeted against active matriptase (as opposed to the zymogen form) have also been developed [23] and used to detect tumors in mice via binding to active matriptase on the surface of cancer cells [24], [25]. The gene discussed is ST14; the disease is cancer.